FDA has approved 54 Emergency INDs to allow access to leronlimab for severely and critically ill COVID-19 patients VANCOUVER, Washington and WINSTON-SALEM, May 07, 2020 — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a […]
VANCOUVER, Washington, April 15, 2020 — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today it has […]
Numerous complaints about fraudulent billing practices have been emerging from Regus offices. It appears the company is desperate for cash. Story developing…
VANCOUVER, Washington, Feb 12, 2020 (GLOBE NEWSWIRE via COMTEX) — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, […]
September 26, 2019 conference presenters: Hoth Therapeutics, Inc. (NASDAQ: HOTH) CEO Robb Knie, shares the latest updates on Hoth’s pipeline of targeted dermatological therapies, which address multi-billion dollar market opportunities, including: eczema, psoriasis, chronic wound […]
Ready to discover the Next Super Stock on July 17 ?
Tarrytown, NY, May 01, 2019 — Nightfood, Inc. (OTCQB:NGTF), the innovative ice cream company solving America’s $50 billion-dollar nighttime snacking problem, announced today that the company has scheduled a fourth ice cream production run for […]
April 1, 2019 – New York, NY – Wall Street Reporter, the leading name in financial news since 1843, has recently published interviews with CEO’s of some of today’s most talked about biotech and healthcare […]
Surge Exploration (TSX. V: SUR) CEO Interview with Tim Fernback, discussing the company’s cobalt and lithium projects in Canada and Chile.
Eastbridge (OTC BB: EBIG) stock message board for EBIG investors and analysts. EBIG quote. EBIG earnings. EBIG research.EBIG SEC filings. EBIG investor conference